Diagnostic endoscopic procedures on the lower gastrointestinal tract

Series
Gastrointestinal
Status
Published
Date
Number of report
056

Ask the expert

(we accept only company emails)

The report presents a summary of reimbursement situation for diagnostic endoscopic procedures on the lower gastrointestinal tract for benign and malignant diseases in outpatient settings.

The following procedures will be considered:

  • Colonoscopy
  • Rectoscopy
  • Anoscopy

The report will consider both stand-alone diagnostic procedures and in combination with biopsy of lesions.

The only reimbursement within public / statutory health insurance systems is considered.

Report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Manufacturers of endoscope equipment for the lower gastrointestinal tract include:

  • Alltion (Fiber-CS)
  • Aohua Ednoscopy (FHD-CL, VCC)
  • EndoChoice (Fuse)
  • Endomed Systems (Duo, Combo-3)
  • Fujifilm Holdings Corporation (Eluxeo EC, RU, EI, EC)
  • Huger Endoscopy System (CVE)
  • Interscope (EndoRotor)
  • KARL STORZ GmbH & Co. KG (Silver Scope, Tele Pack X GI, Troidl Silver Scope)
  • Olympus (EVIS EXERA-CF, PCF, SIF, CHF-V)
  • Pentax medical (RetroView, MagniView EC, G‑EYE, FCP‑9P)
  • SonoScape (ES-500, EC-430, EC-330)

Table of content is not available at the moment. Report is still ongoing.

28

Jun 2021

In mid-June 2021, the document "Changes and innovations in the 2022 LKF model" (Änderungen und Neuerungen in den LKF-Modellen 2022) was published. The document summarizes the most significant changes and innovations in the LKF model for inpatient and outpatient care. The newly added procedure codes concern mainly the cardiovascular, e-Health, and gastrointestinal area.

Read more

09

Jun 2021

For the first time in three years, the Institute for Quality and Efficiency in Health Care (IQWiG) received data within the framework of the early benefit assessment of new examination and treatment methods (NUB) with high-risk medical devices according to §137h of Social Code Book (SGB) V. This involves seven invasive therapeutic cardiovascular, pulmonary, neurological, gastrointestinal, and urological procedures.

Read more

05

Apr 2021

The Danish Health Authority (Sundhedsstyrelsen) updates the Health Care Classification System (Sundheds-væsenets Klassifikations System, SKS) quarterly. It publishes the results on its website two weeks before the implementation, while the files with the changes are sent to the hospital systems. Most of the newly introduced procedure codes concern the gastrointestinal field.

Read more

12

Feb 2021

In January 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, has published Bulletins 0174 and 0071 with changes to be implemented not later than May 01, 2021. Five new procedure codes related to the areas of men's health, robotic surgery, endoscopy, and orthopedics, as well as three new diagnostic codes, were introduced.

Read more

16

Dec 2020

In November 2020, the Clinical Coding and Schedule Development (CCSD) group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, has published Bulletins 0173 and 0070 with changes to be implemented not later than February 01, 2021. Three new procedure codes were introduced, related to robotic laparoscopy in gynecology, brachytherapy in prostate tumor, and autologous bone marrow aspirate concentrate (BMAC) for osteochondral defects of the knee. Also, four codes for diagnostic tests were added.

Read more
(we accept only company emails)